Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway

Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway

Irregular histone modification and aberrant lncRNAs expression are closely related to the occurrence of tumors including acute myeloid leukemia (AML). However, the effects and specific underlying molecular mechanism of histone deacetylase inhibitors on lncRNA expression in AML cells are unclear. Her...

Full description

Bibliographic Details
Main Authors:	Liman Lin, Yimei Que, Pingfan Lu, Huimin Li, Min Xiao, Xiaojian Zhu, Dengju Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Pharmacology
Subjects:	chidamide VPS9D1-AS1 MEK/ERK signaling pathway proliferation long non-coding RNA acute myeloid leukemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.569651/full

Similar Items

Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
by: Yin Wang, et al.
Published: (2021-09-01)

Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis
by: Huan Lu, et al.
Published: (2021-02-01)

Disruption of Cell Spreading by the Activation of MEK/ERK Pathway is Dependent on AP-1 Activity
by: Xu, Feng, et al.
Published: (2010)

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
by: Xuejie Jiang, et al.
Published: (2021-03-01)

The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Kubin Thomas, et al.
Published: (2020-09-01)

Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways
by: David L. Vesely
Published: (2011-03-01)

RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal Cancer through the stabilization of MEKK1 mRNA
by: Meng Zhang, et al.
Published: (2021-06-01)

Bcl-2 Regulates Chondrocyte Phenotype Through MEK-ERK1/2 Pathway; Relevance to Osteoarthritis and Cartilage Biology
by: Yagi, Rieko
Published: (2005)

miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1
by: Wang JH, et al.
Published: (2017-02-01)

PLK1 as a potential prognostic marker of gastric cancer through MEK-ERK pathway on PDTX models
by: Dang SC, et al.
Published: (2018-09-01)

Oxidized LDL Downregulates ABCA1 Expression via MEK/ERK/LXR Pathway in INS-1 Cells
by: Jingya Lyu, et al.
Published: (2021-08-01)

Chidamide in the treatment of peripheral T-cell lymphoma
by: Chan TS, et al.
Published: (2017-01-01)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
by: Naveen Kumar Tangudu, et al.
Published: (2019-05-01)

CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway
by: Zhang B, et al.
Published: (2020-09-01)

The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells
by: Jana Nováková, et al.
Published: (2019-02-01)

TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
by: Hui Shi, et al.
Published: (2021-03-01)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
by: Pui-Kei Wu, et al.
Published: (2020-07-01)

BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway
by: Fenfen Wang, et al.
Published: (2018-11-01)

Bufalin inhibits the growth and epithelial to mesenchymal transition of human gastric cancer cells via modulation of MEK/ERK pathway
by: Yi Zhou, et al.
Published: (2021-01-01)

The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer
by: Zhang W, et al.
Published: (2020-05-01)

Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases
by: Du L, et al.
Published: (2020-07-01)

The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer
by: Patrick J. Klein, et al.
Published: (2006-01-01)

The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis
by: Jung-Min Kim, et al.
Published: (2019-04-01)

Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells
by: Shaojun Wang, et al.
Published: (2019-11-01)

Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression
by: Shuang Tian, et al.
Published: (2018-11-01)

Tubeimoside I Inhibits Cell Proliferation and Induces a Partly Disrupted and Cytoprotective Autophagy Through Rapidly Hyperactivation of MEK1/2-ERK1/2 Cascade via Promoting PTP1B in Melanoma
by: Juan Du, et al.
Published: (2020-12-01)

SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway
by: Ren H, et al.
Published: (2019-04-01)

Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway
by: Changqian eWang, et al.
Published: (2016-03-01)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
by: Yuankai Shi, et al.
Published: (2017-03-01)

Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling
by: Zhili Chu, et al.
Published: (2018-09-01)

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL
by: Chong Wei, et al.
Published: (2021-06-01)

Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
by: Wei Zhang, et al.
Published: (2019-05-01)

Transcriptional Activation of Gstp1 by MEK/ERK Signaling Confers Chemo-Resistance to Cisplatin in Lung Cancer Stem Cells
by: Jingyuan Li, et al.
Published: (2019-06-01)

KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
by: Zhao H, et al.
Published: (2019-02-01)

Periodic mechanical stress activates MEK1/2-ERK1/2 mitogenic signals in rat chondrocytes through Src and PLCγ1
by: Kewei Ren, et al.
Published: (2011-12-01)

Periodic mechanical stress activates MEK1/2-ERK1/2 mitogenic signals in rat chondrocytes through Src and PLCγ1
by: Kewei Ren, et al.
Published: (2011-12-01)

Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer
by: Nan Cui, et al.
Published: (2020-11-01)

Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
by: Alice Iezzi, et al.
Published: (2018-10-01)

Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet.
by: Grant A. McArthur
Published: (2015-07-01)

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01)

Cannot write session to /tmp/vufind_sessions/sess_pp4om476bgr6a24gtssol22821